| Date | Title | Description | Source |
| 12.03.2024 | Clearside Biomedical Announces Fourth Quarter and Full Year ... | - Phase 2b ODYSSEY Wet AMD Trial Remains on Track with Topline Data Expected in Q3 2024 -
- Partner ... | einpresswi... |
| 07.02.2024 | Clearside Biomedical Announces Pricing of $15 Million Regist... | - | globenewsw... |
| 14.08.2023 | Clearside Biomedical Announces Second Quarter 2023 Financial... | - Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Progressing as Planned with Nearly 30 Sites Now Open -... | einpresswi... |
| 21.12.2021 | Clearside Biomedical : CLSD-CLS-AX OASIS Results Slide Prese... | OASIS Phase 1/2a Clinical Trial Safety Results December 21, 2021
Forward-Looking Statements
This pre... | marketscre... |
| 16.08.2021 | Arctic Vision Announces Expansion of License Territory for S... | SHANGHAI, Aug. 16, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on inno... | en.prnasia... |
| 16.08.2021 | Arctic Vision : Announces Expansion of License Territory for... | SHANGHAI, Aug. 15, 2021 /PRNewswire/ -- Arctic Vision, a China-based biotech company focused on inno... | marketscre... |
| 15.08.2021 | Arctic Vision Announces Expansion of License Territory for S... | | prnewswire... |
| 28.04.2016 | Clearside Biomedical, Inc. to Present Data on Suprachoroidal... | ALPHARETTA, Ga.–(BUSINESS WIRE)–April 28, 2016–
Clearside Biomedical, Inc. today announced four post... | venturebea... |
| 26.04.2016 | Clearside Biomedical, Inc. Announces Positive Preliminary Ph... | Patients receiving a single treatment of ZUPRATA™ together with EYLEA® qualified for 60% fewer addit... | venturebea... |
| 29.02.2016 | Clearside Biomedical, Inc. Announces Appointment of Richard ... | ALPHARETTA, Ga.–(BUSINESS WIRE)–February 29, 2016–
Clearside Biomedical, Inc., a late-stage clinical... | venturebea... |
| 08.01.2016 | Clearside Biomedical, Inc. Files Registration Statement for ... | ALPHARETTA, Ga.–(BUSINESS WIRE)–January 8, 2016–
Clearside Biomedical, Inc., a late-stage clinical b... | venturebea... |
| 05.01.2016 | Clearside Biomedical, Inc. Announces Positive Topline Data f... | Clinical Trial Achieves Statistical Significance on Primary Efficacy Endpoint
ALPHARETTA, Ga.–(BUSIN... | venturebea... |
| 14.12.2015 | Clearside Biomedical, Inc. Completes Enrollment in Phase 2 C... | ALPHARETTA, Ga.–(BUSINESS WIRE)–December 14, 2015–
Clearside Biomedical, Inc., a late-stage clinical... | venturebea... |
| 08.12.2015 | Clearside Biomedical gets $20M for drug-device combo for bli... | Clearside has three clinical trials for macular edema underway using CLS-TA, its proprietary formula... | medcitynew... |
| 07.12.2015 | Clearside Biomedical, Inc. Enrolls First Patient in Phase 3 ... | First Patient Randomized in Six-Month Efficacy Trial for the Treatment of Macular Edema Associated w... | venturebea... |
| 03.12.2015 | Clearside Biomedical Closes $20M Series C Financing | Clearside Biomedical, Inc., an Alpharetta, GA-based clinical-stage biopharmaceutical company develop... | finsmes.co... |
| 03.12.2015 | Clearside Biomedical, Inc. Completes $20 Million Series C Fi... | ALPHARETTA, Ga.–(BUSINESS WIRE)–December 3, 2015–
Clearside Biomedical, Inc., a clinical-stage bioph... | venturebea... |
| 12.11.2015 | Clearside Biomedical, Inc. Announces Fifth Patent Issued in ... | ALPHARETTA, Ga.–(BUSINESS WIRE)–November 12, 2015–
Clearside Biomedical, Inc., a clinical-stage biop... | venturebea... |
| 12.10.2015 | Clearside Biomedical, Inc. Completes Enrollment in Phase 2 C... | For the Treatment of Macular Edema Associated with Non-Infectious Uveitis
ALPHARETTA, Ga.–(BUSINESS ... | venturebea... |
| 24.09.2015 | Clearside Biomedical, Inc. Announces 50th Patient Enrolled U... | Major Milestone for Innovative Ophthalmic Drug Administration Platform
ALPHARETTA, Ga.–(BUSINESS WIR... | venturebea... |
| 22.09.2015 | Clearside Biomedical, Inc. to Present at the 13th Congress o... | Hosted by the Foster Ocular Immunology Society (FOIS)
ALPHARETTA, Ga.–(BUSINESS WIRE)–September 22, ... | venturebea... |
| 09.07.2015 | Clearside Biomedical, Inc. to Present at International Sympo... | ALPHARETTA, Ga.–(BUSINESS WIRE)–July 9, 2015–
Clearside Biomedical, Inc., a clinical-stage biopharma... | venturebea... |
| 16.06.2015 | Clearside Biomedical, Inc. Announces Favorable End-of-Phase ... | Plans to initiate a Phase 3 clinical study for the treatment of macular edema associated with non-in... | venturebea... |
| 04.05.2015 | Clearside Biomedical, Inc. and Santen, Inc. Announce Researc... | Expands Previous Research Collaboration to Include 2nd Largest Ophthalmic Market
ALPHARETTA, Ga. &am... | venturebea... |
| 30.04.2015 | Clearside Biomedical, Inc. to Report Efficacy and Safety Res... | ALPHARETTA, Ga.–(BUSINESS WIRE)–April 30, 2015–
Clearside Biomedical, Inc., a clinical-stage biophar... | venturebea... |
| 22.04.2015 | Clearside Biomedical, Inc. Announces Purchase of iScience Pa... | ALPHARETTA, Ga.–(BUSINESS WIRE)–April 22, 2015–
Clearside Biomedical, Inc., a clinical-stage biophar... | venturebea... |
| 16.03.2015 | Clearside Biomedical, Inc. Reports Efficacy and Safety Resul... | Patients Treated in the Clinical Trial Exhibited Improvement in Best Corrected Visual Acuity No Mean... | venturebea... |
| 02.03.2015 | Clearside Biomedical, Inc. Initiates Phase 2 Clinical Trial ... | Follows the recent initiation of Clearside’s Phase 2 clinical trial for the treatment of macular ede... | venturebea... |
| 05.01.2015 | Clearside Biomedical, Inc. Initiates Phase 2 Clinical Trial ... | ALPHARETTA, Ga.–(BUSINESS WIRE)–January 5, 2015–
Clearside Biomedical, Inc., a clinical-stage biopha... | venturebea... |
| 15.10.2014 | Clearside Biomedical, Inc. Announces Ongoing Results in Phas... | ALPHARETTA, Ga.–(BUSINESS WIRE)–October 15, 2014–
Clearside Biomedical, Inc. today announced the eig... | venturebea... |
| 02.09.2014 | Clearside Biomedical Closes $16M Series B Financing | Clearside Biomedical, Inc., an Alpharetta, GA-based clinical-stage biopharmaceutical company, closed... | finsmes.co... |
| 02.09.2014 | Clearside Biomedical Lands $16M in Series B |
ALPHARETTA, GA, Clearside Biomedical, Inc., today announced the closing of a $16 million Series B ... | vcnewsdail... |
| 18.02.2013 | Ophthalmology startup uses microneedles for targeted deliver... | According to a statement from the company, the funding came from Santen Inc., the California-based s... | medcitynew... |
| 20.02.2012 | Eye treatments firm Clearside close to $4M raise for microne... | Clearside is developing a novel drug-delivery platform for the eyes. Right now, doctors can deliver ... | medcitynew... |
| 15.02.2012 | Pharmas, medical device makers set to pitch at CED Life Scie... | A total of 16 companies are scheduled to make presentations, split evenly between pharmaceuticals an... | medcitynew... |
| 06.01.2012 | Clearside Biomedical Launches with $4M Series A Venture Fina... | Clearside Biomedical, an Atlanta, GA-based ophthalmic startup specializing in the research, developm... | finsmes.co... |
| 05.01.2012 | Clearside raises $4M for targeted drug delivery system and n... | Clearside will direct the investment toward development of its novel microinjection drug delivery pl... | medcitynew... |
| 05.01.2012 | Clearside Biomedical Launched with $4M Series A |
ATLANTA, GA, Ophthalmic startup Clearside Biomedical and Hatteras Venture Partners announced that ... | vcnewsdail... |
| - | Pharmas, medical device makers set to pitch at CED Life Scie... | Life science companies and investors, let’s make a deal.
The annual CED Life Science Conference kick... | medcitynew... |
| - | Clearside raises $4M for targeted drug delivery system and n... | Ophthalmic startup Clearside Biomedical has launched with a $4 million initial round of investment f... | medcitynew... |
| - | Ophthalmology startup uses microneedles for targeted deliver... | A one-year-old company using drug delivery to improve ophthalmic drugs is raising fresh capital to s... | medcitynew... |
| - | Clearside Biomedical gets $20M for drug-device combo for bli... | Clearside Biomedical just closed a $20 million C round to further clinical work on its drug-device c... | medcitynew... |
| - | Eye treatments firm Clearside close to $4M raise for microne... | Ophthalmic treatments company Clearside Biomedical is nearly finished raising its $4 million first r... | medcitynew... |
